BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8072372)

  • 21. A novel substance P binding site in rat brain regions modulates TRH receptor binding.
    Sharif NA
    Neurochem Res; 1990 Oct; 15(10):1045-9. PubMed ID: 1706485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diversity of thyrotropin-releasing hormone receptors in the pituitary and discrete brain regions of rats.
    Asai H; Kinoshita K; Yamamura M; Matsuoka Y
    Jpn J Pharmacol; 1999 Mar; 79(3):313-7. PubMed ID: 10230859
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Micromolar substance P reduces spinal receptor binding for thyrotropin-releasing hormone--possible relevance to neuropeptide coexistence?
    Sharif NA; Burt DR
    Neurosci Lett; 1983 Dec; 43(2-3):245-51. PubMed ID: 6200806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Binding of 3H-(3-MeHis2) thyrotropin-releasing hormone to spinal cord membranes of spontaneously hypertensive and Wistar-Kyoto normotensive rats.
    Bhargava HN; Gulati A
    Pharmacology; 1988; 37(6):349-55. PubMed ID: 2854272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brain receptor binding characteristics and pharmacokinetics of JTP-2942, a novel thyrotropin-releasing hormone (TRH) analogue.
    Urayama A; Yamada S; Deguchi Y; Kimura R; Maeda Y; Kobayashi T
    Life Sci; 1999; 65(22):2407-15. PubMed ID: 10597895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro biochemical characterization and autoradiographic distribution of 3H-thyrotropin-releasing hormone binding sites in rat brain sections.
    Rostène WH; Morgat JL; Dussaillant M; Rainbow TC; Sarrieau A; Vial M; Rosselin G
    Neuroendocrinology; 1984 Jul; 39(1):81-6. PubMed ID: 6087185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Norvaline2-TRH: binding to TRH receptors in rat brain homogenates.
    Vonhof S; Feuerstein GZ; Cohen LA; Labroo VM
    Eur J Pharmacol; 1990 May; 180(1):1-12. PubMed ID: 2163861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stereoselectivity of kappa-opiate receptor ligands in inhibiting the binding of [3H][3-MeHis2]thyrotrophin releasing hormone to brain membranes.
    Bhargava HN; Das S; Gulati A
    J Pharm Pharmacol; 1988 Jan; 40(1):70-2. PubMed ID: 2896784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel TRH analog, Glp-Asn-Pro-D-Tyr-D-TrpNH2, binds to [3H][3-Me-His2]TRH-labelled sites in rat hippocampus and cortex but not pituitary or heterologous cells expressing TRHR1 or TRHR2.
    Hogan N; O'Boyle KM; Hinkle PM; Kelly JA
    Neurosci Lett; 2008 Jan; 431(1):26-30. PubMed ID: 18069127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thyrotropin-releasing hormone (TRH) receptors. Localization by light microscopic autoradiography in rat brain using [3H][3-Me-His2]TRH as the radioligand.
    Mantyh PW; Hunt SP
    J Neurosci; 1985 Feb; 5(2):551-61. PubMed ID: 2983042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biochemical similarity of rat pituitary and CNS TRH receptors.
    Sharif NA; Burt DR
    Neurosci Lett; 1983 Aug; 39(1):57-63. PubMed ID: 6314192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sphingosine inhibits thyrotropin-releasing hormone binding to pituitary cells by a mechanism independent of protein kinase C.
    Winicov I; Gershengorn MC
    J Biol Chem; 1988 Sep; 263(25):12179-82. PubMed ID: 3137221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Importance of extracellular domains for ligand binding in the thyrotropin-releasing hormone receptor.
    Han B; Tashjian AH
    Mol Endocrinol; 1995 Dec; 9(12):1708-19. PubMed ID: 8614407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Release of thyrotropin and prolactin by a thyrotropin-releasing hormone (TRH) precursor, TRH-Gly: conversion to TRH is sufficient for in vivo effects.
    Pekary AE; Stephens R; Simard M; Pang XP; Smith V; DiStefano JJ; Hershman JM
    Neuroendocrinology; 1990 Dec; 52(6):618-25. PubMed ID: 2126612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thyrotropin releasing hormone (TRH) binding sites in the adult human brain: localization and characterization.
    Parker CR; Capdevila A
    Peptides; 1984; 5(4):701-6. PubMed ID: 6093073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Binding of [3H]batrachotoxinin A-20-alpha-benzoate and [3H]saxitoxin to receptor sites associated with sodium channels in trout brain synaptoneurosomes.
    Rubin JG; Soderlund DM
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1993 Jun; 105(2):231-8. PubMed ID: 8103729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rat brain TRH receptors: kinetics, pharmacology, distribution and ionic effects.
    Sharif NA; Burt DR
    Regul Pept; 1983 Dec; 7(4):399-411. PubMed ID: 6322242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kinetics and pattern of degradation of thyrotropin-releasing hormone (TRH) in human plasma.
    Møss J; Bundgaard H
    Pharm Res; 1990 Jul; 7(7):751-5. PubMed ID: 2118634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distribution of thyrotropin-releasing hormone binding sites: autoradiographic study in infant and adult human hippocampal formation.
    Eymin C; Champier J; Duvernoy HM; Martin D; Kopp N; Jordan D
    Brain Res; 1993 Mar; 605(1):139-46. PubMed ID: 8467383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence for opiate action at the brain receptors for thyrotropin-releasing hormone.
    Bhargava HN; Das S
    Brain Res; 1986 Mar; 368(2):262-7. PubMed ID: 3008927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.